Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 86Lymphoid 63Other hematologic neoplasm 46CNS 7Myeloid 6Thoracic 5Genitourinary 5Breast 4Gynecologic 3Gastrointestinal 3Tumor-Agnostic 2Sarcoma 2Other 1Head & Neck 1Dermatologic 1Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Pain 1Deglutition Disorders 1

Interventions

Cisplatin 620pembrolizumab 323Radiotherapy 319Cetuximab 275Docetaxel 221Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 75Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 50Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 44Standard of Care 43tislelizumab 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × dexamethasone acetate × Head & Neck × Clear all
NCT01748942 2018-06-19

Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

OHSU Knight Cancer Institute

Phase NA Completed
76 enrolled 20 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡